Patanjali Ayurved Apologizes to Supreme Court Over Misleading Advertisements
Patanjali Ayurved, led by CEO Acharya Balkrishna, has issued an apology before the Supreme Court in response to criticism and contempt proceedings initiated against them for misleading advertisements and criticism of modern medicine. This move comes after the Supreme Court summoned Patanjali Ayurved and its managing director to personally appear and address the contempt proceedings.
The apology, conveyed through an affidavit filed by Acharya Balkrishna, expresses the company’s highest regard for the rule of law and extends an ‘unqualified apology’ for the misleading claims made about its products’ medicinal efficacy. Balkrishna assures the court that Patanjali Ayurved will take measures to ensure that such misleading advertisements are not issued in the future.
The affidavit was submitted following the Supreme Court’s reprimand of Patanjali Ayurved for not responding to a contempt notice regarding misleading advertisements. The court had directed both Balkrishna and Ramdev to appear in court on April 2 to address the matter.
In the affidavit, Balkrishna stated, “The Deponent on behalf of Respondent No. 5 submits an unqualified apology before this Hon’ble Court for the breach of the statement recorded in the order of November 21, 2023.” He further added that Patanjali Ayurved will ensure such advertisements are not issued in the future, clarifying that their intention is to promote a healthier lifestyle using products backed by Ayurvedic research.
The Supreme Court is currently hearing a petition filed by the Indian Medical Association (IMA), alleging a smear campaign by Ramdev against the Covid vaccination drive and modern medicine. Patanjali Ayurved’s apology signals a willingness to address concerns raised by the medical community and comply with legal obligations amidst this legal battle.
